Castle Biosciences Inc financial data

Symbol
CSTL on Nasdaq
Industry
Services-Medical Laboratories
Location
505 S Friendswood Drive, Suite 401, Friendswood, TX
State of incorporation
DE
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2024 - Aug 5, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 767 % -10.6%
Quick Ratio 18.9 % +35.3%
Debt-to-equity 14.5 % +24.4%
Return On Equity -0.77 % +96.6%
Return On Assets -0.68 % +96.7%
Operating Margin -5.48 % +90.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.7M shares +3.46%
Common Stock, Shares, Outstanding 27.7M shares +3.46%
Entity Public Float 311M USD -34.1%
Weighted Average Number of Shares Outstanding, Basic 27.6M shares +3.42%
Weighted Average Number of Shares Outstanding, Diluted 28.7M shares +7.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 288M USD +71.7%
Cost of Revenue 52.2M USD +31.6%
Research and Development Expense 53.9M USD +7.9%
Operating Income (Loss) -15.8M USD +83.8%
Income Tax Expense (Benefit) -918K USD -1155%
Net Income (Loss) Attributable to Parent -3.1M USD +96.5%
Earnings Per Share, Basic -0.11 USD/shares +96.7%
Earnings Per Share, Diluted -0.12 USD/shares +96.4%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 85.6M USD -10.7%
Accounts Receivable, after Allowance for Credit Loss, Current 46M USD +46.9%
Inventory, Net 8.01M USD +30.9%
Assets, Current 320M USD +19.1%
Property, Plant and Equipment, Net 22.3M USD +70.6%
Operating Lease, Right-of-Use Asset 11.6M USD +0.71%
Goodwill 10.7M USD 0%
Other Assets, Noncurrent 2.68M USD +125%
Assets 487M USD +14.6%
Accounts Payable, Current 9.54M USD +33.7%
Employee-related Liabilities, Current 21.2M USD +22.8%
Liabilities, Current 39.5M USD +17%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 13.6M USD +9.8%
Other Liabilities, Noncurrent 16K USD -70.9%
Liabilities 63.4M USD +36%
Accumulated Other Comprehensive Income (Loss), Net of Tax -172K USD -19.4%
Retained Earnings (Accumulated Deficit) -212M USD -1.48%
Stockholders' Equity Attributable to Parent 424M USD +11.9%
Liabilities and Equity 487M USD +14.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -6.84M USD +73.1%
Net Cash Provided by (Used in) Financing Activities 10.6M USD +1362%
Net Cash Provided by (Used in) Investing Activities -19.7M USD -219%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 27.7M shares +3.46%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -15.9M USD -95.5%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 85.6M USD -10.7%
Deferred Tax Assets, Valuation Allowance 55M USD +10.2%
Deferred Tax Assets, Gross 79.5M USD +3.73%
Operating Lease, Liability 15.3M USD +15%
Depreciation 4.05M USD +49.6%
Payments to Acquire Property, Plant, and Equipment 9.15M USD +174%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -3.13M USD +96.5%
Lessee, Operating Lease, Liability, to be Paid 24.3M USD +4.37%
Operating Lease, Liability, Current 1.23M USD -37.6%
Lessee, Operating Lease, Liability, to be Paid, Year Two 2.25M USD +6.08%
Lessee, Operating Lease, Liability, to be Paid, Year One 2.33M USD +26.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +13.7%
Deferred Income Tax Expense (Benefit) 0 USD -100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 9M USD -9.85%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.24M USD +11%
Deferred Tax Assets, Operating Loss Carryforwards 47.2M USD -4.25%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.46M USD +12.7%
Additional Paid in Capital 636M USD +8.21%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 9.04M USD +0.51%
Depreciation, Depletion and Amortization 3.34M USD +15.5%
Deferred Tax Assets, Net of Valuation Allowance 24.5M USD -8.31%
Share-based Payment Arrangement, Expense 50.7M USD +11.4%
Interest Expense 234K USD +1276%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%